Celebrex and Mastication disorder - a phase IV clinical study of FDA data
Summary:
Mastication disorder is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years also take Zometa, and have Metastases to bone.
The phase IV clinical study analyzes which people have Mastication disorder when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.
What is Celebrex?
Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.
What is Mastication disorder?
Mastication disorder (disease of chewing food) is found to be associated with 713 drugs and 548 conditions by eHealthMe. Check the latest studies of Mastication disorder.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
147,540 people reported to have side effects when taking Celebrex.
Among them, 251 people (0.17%) have Mastication disorder.

Among these 251 people:
How long have people been on Celebrex when they have Mastication disorder? *
What is the gender of people who have Mastication disorder when taking Celebrex? *
What is the age of people who have Mastication disorder when taking Celebrex? *
What are other drugs people take besides Celebrex? *
What are other side effects people have besides Mastication disorder? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Celebrex and have Mastication disorder?
- Check whether Mastication disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Celebrex:
- Celebrex (151,105 reports)
Mastication disorder treatments and more:
- Mastication disorder (4,453 reports)
How severe was Mastication disorder and when was it recovered:
Expand to all the drugs that have ingredients of celecoxib:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Celebrex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Mastication disorder:
- Mastication disorder (713 drugs)
Browse all the conditions that are associated with Mastication disorder:
- Mastication disorder (548 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lovastatin and Hydroxyzine drug interactions for women aged 40-49 - now
- Could Lisinopril cause Diastolic Dysfunction? - now
- Omeprazole vs. Tagamet Hb 200, side effect and effectiveness comparison - 10 seconds ago
- Burning Sensation and drugs of ingredients of carfilzomib - 14 seconds ago
- Major Depression and drugs of ingredients of cyanocobalamin - 17 seconds ago
- Olanzapine and Tumour Lysis Syndrome for Men aged 60+ - 22 seconds ago
- Olanzapine and Tumor Lysis Syndrome for Men aged 60+ - 22 seconds ago
- Celexa and Procedural Pain for Women aged 20-29 - 33 seconds ago
- Could Minocycline Hydrochloride cause Ankylosing Spondylitis? - 34 seconds ago
- Could Metoprolol Succinate cause Adverse Reaction? - 38 seconds ago